Pros | ![]() 5Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() Larger AUM within category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | ![]() 5Y returns in the bottom 25% of the category. ![]() 3Y returns in the bottom 25% of the category. |
INDMoney rank | 2/8 | 7/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 9 Years | 12 Years | ||
Fund Size | 1339 Cr | 8737 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.61% | 0.89% | ||
Exit Load | 0.25% | 1% | ||
Benchmark Index | Nifty Pharma TR INR | BSE Healthcare TR INR |
No of Holdings | 37 | 41 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (10.92%) Cipla Ltd (6.62%) Apollo Hospitals Enterprise Ltd (5.2%) Lupin Ltd (4.77%) HealthCare Global Enterprises Ltd (4.38%) | Sun Pharmaceuticals Industries Ltd (12.22%) Divi's Laboratories Ltd (7.55%) Lupin Ltd (5.93%) Cipla Ltd (5.69%) Dr Reddy's Laboratories Ltd (5.69%) | ||
No of Sectors | 3 | 1 | ||
Top 3 Sectors | Health (97.77%) Financial Services (1.74%) Basic Materials (0.49%) | Health (100%) | ||
Equity % | 93.78% | 99.45% | ||
Debt % | - | - | ||
P/E | 39.82 | 37.97 | ||
P/B | 6.05 | 6.05 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 0.84% | -0.28% | ||
3-Month Return | 5.34% | 2.46% | ||
6-Month Return | 15.88% | 13.27% | ||
1-Year Return | 0.67% | 0.08% | ||
3-Year Return | 25.94% | 24.54% | ||
5-Year Return | 21.14% | 20.19% |
Sharpe | 1.08 | 1.06 | ||
Alpha | 4.38 | 0.66 | ||
Beta | 0.94 | 0.91 | ||
Standard Deviation | 15.97 | 15.05 | ||
Information Ratio | 1.35 | -0.24 |
Description | Tata India Pharma & Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rajat Srivastava | Sailesh Raj Bhan,Kinjal Desai |